Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Eukaryotic Gene Expression
Fator do impacto: 1.841 FI de cinco anos: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN On-line: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v10.i2.10
14 pages

Therapeutic Angiogenesis: A Case for Targeted, Regulated Gene Delivery

Keith A. Webster
Department of Molecular and Cellular Pharmacology, University of Miami Medical Center, 1600 NW 10th Avenue, RMSB 6038, Miami, FL 33136


Blood and vascular disorders underlie a plethora of pathological conditions and are the single most frequent cause of human disease. Eliminated or restricted blood flow to tissues as a result of vessel dysfunction results in the disruption of oxygen and nutrient delivery and the accumulation of waste metabolites. Cells cannot survive extended severe ischemia but may be able to adapt to a moderate condition where diffusion to and from bordering nonischemic regions sustain vital functions. Under this condition, secondary functions of affected cells are likely to be impaired and a new metabolic equilibrium is established, determined by the level of cross-diffusion. In tissues with a normally high metabolic turnover such as skeletal and cardiac muscle, ischemia causes hypoxia, acidosis, and depressed function (contractility). The treatment possibilities for tissue ischemia resulting from vascular disease are limited. Lipid-lowering agents may help slow the progression of vessel disease in some instances, but surgical reconstruction may be the only option in advanced stages, and even this is not always an option. An alternative and rather obvious strategy to treat ischemia is to activate endogenous angiogenic or vasculogenic pathways and stimulate revascularization of the tissue. The feasibility of such a strategy has now been established through the results of studies over the past decade and a new discipline called therapeutic angiogenesis has emerged. This review focuses on the application of therapeutic angiogenesis for treating peripheral limb ischemia and coronary artery diseases; the author traces the evidence supporting the feasibility of this treatment strategy, its current limitations, and possible directions.

Articles with similar content:

Neurodegenerative Disorders: Clues from Glutamate and Energy Metabolism
Critical Reviews™ in Neurobiology, Vol.10, 1996, issue 2
Lechoslaw Turski, Chrysanthy Ikonomidou
An Overview of Parkinson's Disease and Oxidative Stress: Herbal Scenario
Neuropathological Diseases, Vol.1, 2012, issue 2
Pavan Kumar Padarthi, Elangovan Namasivayam, Richard L. Jayaraj, D. John Ravindar, K. Manigandan
Effect of Circadian Rhythm on Clinical and Pathophysiological Conditions and Inflammation
Critical Reviews™ in Immunology, Vol.35, 2015, issue 4
Shogo Sato, Takako Kizaki, Hideki Ohno, Tetsuya Izawa, Kenji Suzuki, Yoshinobu Ohira, Takuya Sakurai, Junetsu Ogasawara, Ken Shirato
Rehabilitation Modalities in Palliative Care
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.25, 2013, issue 1-2
Danielle Perret Karimi, Bianca Tribuzio, Edward L. Barawid, Solomon Liao, Natalia Covarrubias
Intracellular Pattern Recognition Receptors and Renal Ischemia
Critical Reviews™ in Immunology, Vol.31, 2011, issue 4
Dianne B. McKay